Litcius/Paper detail

Can the GeneXpert MTB/XDR deliver on the promise of expanded, near-patient tuberculosis drug-susceptibility testing?

Kogieleum Naidoo, Navisha Dookie

2022The Lancet Infectious Diseases35 citationsDOI

Topics & Concepts

MedicineTuberculosisGeneXpert MTB/RIFExtensively drug-resistant tuberculosisDrug resistanceMycobacterium tuberculosisDrugIsoniazidDrug resistant tuberculosisIntensive care medicineVirologyEthionamideMulti-drug-resistant tuberculosisPharmacologyEthambutolMicrobiologyPathologyBiologyTuberculosis Research and EpidemiologyPneumonia and Respiratory InfectionsPneumocystis jirovecii pneumonia detection and treatment
Can the GeneXpert MTB/XDR deliver on the promise of expanded, near-patient tuberculosis drug-susceptibility testing? | Litcius